Fennec Pharmaceuticals (FENC) CEO receives 1,159-share stock award

Rhea-AI Filing Summary

Fennec Pharmaceuticals Inc. reported that Chief Executive Officer Jeffrey S. Hackman acquired 1,159 Common Shares as a grant or award. The shares were released from restriction from an award originally granted on 3/28/2025 and carried a transaction price of $0.00 per share.

Following this compensation-related acquisition, Hackman directly owns 62,825 Common Shares. The filing reflects routine equity compensation rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hackman Jeffrey S.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	1,159	$0.00	--

Holdings After Transaction: Common Shares — 62,825 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares acquired: 1,159 Common Shares Transaction price: $0.00 per share Post-transaction holdings: 62,825 Common Shares +2 more

5 metrics

Shares acquired 1,159 Common Shares Grant, award, or other acquisition on 2026-05-31

Transaction price $0.00 per share Equity award, not open-market trade

Post-transaction holdings 62,825 Common Shares Direct ownership by CEO after award

Transaction code A (Grant, award, or other acquisition) Form 4 non-derivative transaction classification

Award source date March 28, 2025 Shares released from restriction from 3/28/2025 award

Key Terms

Common Shares, Grant, award, or other acquisition, shares released from restriction, Form 4

4 terms

Common Shares financial

"security_title: "Common Shares""

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

shares released from restriction financial

"Represents shares released from restriction from shares awarded 3/28/2025."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hackman Jeffrey S.

(Last) (First) (Middle)

68 TW ALEXANDER DRIVE

PO BOX 13628

(Street)

RESEARCH TRIANGLE PARK NORTH CAROLINA 27709

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FENNEC PHARMACEUTICALS INC. [ FENC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares(1)	05/31/2026		A		1,159	A	$0	62,825	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares released from restriction from shares awarded 3/28/2025.

	/s/ Jeffrey Hackman	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Fennec (FENC) report for its CEO?

Fennec reported that CEO Jeffrey S. Hackman acquired 1,159 Common Shares. The shares were granted at $0.00 per share as equity compensation, reflecting release of restrictions from an award originally granted on March 28, 2025, and increasing his direct holdings.

Was the Fennec (FENC) CEO’s Form 4 transaction a market purchase or sale?

The CEO’s Form 4 transaction was not a market trade. It is coded “A” as a grant, award, or other acquisition, representing restricted shares released from a prior award, with a transaction price of $0.00 per share rather than an open-market buy or sell.

How many Fennec (FENC) shares does the CEO hold after this Form 4?

After the reported transaction, CEO Jeffrey S. Hackman directly holds 62,825 Common Shares. This total includes the 1,159 shares that were released from restriction from an equity award originally granted on March 28, 2025, and reported as a grant-type acquisition.

What does the 1,159-share award mean for Fennec (FENC) investors?

The 1,159-share award reflects routine equity compensation for Fennec’s CEO. It shows the company continuing to use stock-based compensation, with shares released from restriction on a prior grant, rather than signaling a discretionary open-market purchase or sale by the executive.

How is the CEO’s Fennec (FENC) share award classified on Form 4?

The transaction is classified with code “A” for grant, award, or other acquisition. It covers 1,159 Common Shares at a transaction price of $0.00, described in the footnote as shares released from restriction from an award granted on March 28, 2025.